We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00906217
First Posted: May 21, 2009
Last Update Posted: September 15, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Lawrence Hookey, Queen's University
May 19, 2009
May 21, 2009
September 15, 2011
January 2009
July 2010   (Final data collection date for primary outcome measure)
serum electrolyte changes pre and post preparation [ Time Frame: 2 months ]
Same as current
Complete list of historical versions of study NCT00906217 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population
Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population
This study aims to further define the appropriate population for Pico-Salax, a purgative used prior to colonoscopy. Patients over the age of 70 years with normal renal function scheduled for colonoscopy will receive Pico-Salax and have pre and post preparation bloodwork and electrocardiograms (ECGs).
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
patients older than 70 scheduled for colonoscopy
Colon Cleansing
Not Provided
elderly patients
patients older than 70 years with normal renal function
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
September 2011
July 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • >70 years

Exclusion Criteria:

  • renal dysfunction
  • congestive heart failure
  • ileus
Sexes Eligible for Study: All
70 Years and older   (Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
Canada
 
NCT00906217
Hookey Picosalax Elderly Trial
No
Not Provided
Not Provided
Lawrence Hookey, Queen's University
Queen's University
Not Provided
Principal Investigator: Lawrence Hookey, MD Queen's University
Queen's University
September 2011